Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News
This week, direct-to-patient healthcare company Ro made it easier for those patients to find where to get their meds with the launch of the GLP-1 Supply Tracker, an interactive tool that provides real-time insights on GLP-1 drug shortages, along with automated, localized supply alerts
Book Your Super B12 IM Injection Session Today Ready to start feeling better
CagriSema REDEFINE 2: Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
Rajabi-Estarabadi, J
Phase 2 dose-finding data The phase 2 trial tested cagrilintide at 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg weekly